Week 24 efficacy and safety of sotagliflozin, a dual sodium-glucose co-transporter-1 (SGLT-1) and SGLT-2 inhibitor, as adjunct therapy to insulin in Type 1 diabetes (inTandem1 and inTandem2 trials)
DIABETIC MEDICINE（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要